HIV Prevention Injection Hailed As a Major Breakthrough for Women

Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a "game-changer" to turn "the tide on HIV". This is according to Professor Helen Rees, Executive Director of the Wits Reproductive Health and HIV Institute, who announced the results via an online media briefing. The study, called HPTN084 and led by the HIV Prevention Trials Network, tested an antiretroviral (ARV) injection given every two months comparing it to the current standard of drug prevention which comes in the form of a daily oral pill. The injection has to be administered by a health professional.

InFocus

(file photo).

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.